Reply to 'Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies'
Nat Rev Cancer
.
2025 Jul;25(7):564-565.
doi: 10.1038/s41568-025-00825-8.
Authors
Sylvain Peuget
1
,
Galina Selivanova
2
Affiliations
1
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Sylvain.Peuget@ki.se.
2
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Galina.Selivanova@ki.se.
PMID:
40379969
DOI:
10.1038/s41568-025-00825-8
No abstract available
Publication types
Letter